Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients

British Journal of Dermatology

Volumn 152, Issue 1, 2005, Pages 66-70

  Machet, Laurent ^a,b   Nemeth Normand, F ^a,b   Giraudeau, B ^c   Perrinaud, A ^a,b   Tiguemounine, J ^a   Ayoub, J ^a   Alison, D ^a   Vaillant, L ^a,b   Lorette, G ^a,b  

^a SERVICE DE DERMATOLOGIE   (France)

^b Oncocentre   (France)

^c CHU BRETONNEAU   (France)

Author keywords

Lymph node; Melanoma; Metastases; Prospective; Ultrasound examination

Indexed keywords

ADULT; AGE; AGE AT DIAGNOSIS; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL EXAMINATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PALPATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; ADOLESCENT; AGED; CONTROLLED STUDY; LYMPHOGRAPHY; METASTASIS; RECURRENT DISEASE; SENSITIVITY ANALYSIS; ULTRASOUND LYMPH NODE EXAMINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PALPATION; PHYSICAL EXAMINATION; PRACTICE GUIDELINES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 13244296964     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06262.x     Document Type: Article

References (17)

1. Hofmann U, Szedlak M, Rittgen W et al. Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival. Br J Cancer 2002; 87:151-7.
2. Anonymous. Suivi des patients opérés d'un mélanome de stade 1. Conférence de consensus. Paris, France, 30 mars 1995. Ann Dermatol Venereol 1995; 122:250-391.
3. Kroon BB, Bergman W, Coebergh JW, Ruiter DJ. Consensus on the management of malignant melanoma of the skin in The Netherlands. Dutch Melanoma Working Party. Melanoma Res 1999; 9:207-12.
4. Roberts DL, Anstey AV, Barlow RJ et al., the British Association of Dermatologists; Melanoma Study Group. U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol 2002; 146:7-17.
5. Huang CL, Provost N, Marghoob AA et al. Laboratory tests and imaging studies in patients with cutaneous malignant melanoma. J Am Acad Dermatol 1998; 39:451-63.
6. Balch CM, Soong SJ, Gershenwald JE et al. Prognostic factors analysis of 17 600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol 2001; 19:3622-34.
7. Voit C, Mayer T, Kron M et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 2001; 91:2409-16.
8. Voit C, Schoengen A, Schwurzer-Voit M et al. The role of ultrasound in detection and management of regional disease in melanoma patients. Semin Oncol 2002; 29:353-60.
9. Trost O, Danino AM, Dutronc Y et al. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma (EJSO 2002; 28:673-8). Eur J Surg Oncol 2003; 29:699.
10. Trost O, Danino AM, Dutronc Y et al. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma (EJSO 2002; 28:673-8). Eur J Surg Oncol 2003; 29:699.
11. Lens MB, Dawes M, Goodacre T, Newton-Bishop JA. Elective lymph node dissection in patients with melanoma. Systematic review and meta-analysis of randomized controlled trials. Arch Surg 2002; 137:458-61.
12. Orfanos CE, Jung EG, Rasner G et al. Stellungnahme und Empfehlungen der Komission malignes Melanom der Deutschen Dcrmatologischen Gesellshaft zur Diagnostik, Behandlung und Nachsorge des malignes Melanoms der Haut. Stand 1993/94. Hautarzt 1994; 45:285-91.
13. Garbe C, Paul A, Kohler-Späth H et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol 2003; 21:520-9.
14. Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 1992; 183:215-20.
15. Tschammler A, Ott G, Schang T et al. Lymphadenopathy: differentiation of benign from malignant disease-color Doppler US assessment of intranodal angioarchitecture. Radiology 1998; 208:117-23.
16. Blum A, Schlagenhauff B, Stroebel W et al. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma. Cancer 2000; 88:2534-9.
17. Autier P, Coebergh JW, Boniol M et al. Management of melanoma patients: benefit of intense follow-up schedule is not demonstrated. J Clin Oncol 2003; 21:3707; author reply 3707-8.